Toggle menu

Seona Burgess

Senior Stroke Research Nurse

Qualifications:
BSc (hons) Nursing Studies
Twitter:
@@birdyburgess
Seona Burgess

Seona graduated from the University of Edinburgh in 2001 with a BSc in Nursing Studies. She then took up her first hospital post in Renal HDU then moved on after a couple of years into Transplant nursing where she worked for 8 years until a spinal injury from International hockey meant redeployment into the less physically demanding role Stroke Research Nurse in 2010.

Since 2010 Seona has enjoyed the wide and varied portfolio of stroke trials she has both recruited to and co-ordinated. Her motivation for research stems from her love of people and striving to find the evidence base for practice in this specialised area.

Outside of work Seona enjoys being with her family, and she in never happier than camping in the woods with her family and a roaring fire.

 

Affilations : NMC and RCN

 

 


Trials

ETNA

ETNA: Edinburgh Transient and Neurological attack: A Cohort Study

Patients frequently present with minor neurological symptoms where a diagnosis of transient ischaemic attack (TIA) or minor stroke is difficult to make positively or to exclude reasonably. For these patients, clinicians are uncertain whether they should: (a) reassure most patients that their symptoms are benign; (b) treat most patients with antiplatelet or other vascular prevention; or (c) stratify stroke risk further using clinical features or brain imaging.
This is important because clinical diagnosis is difficult. Mis-diagnosis is not infrequent and leads to harm from preventable recurrent stroke and costs to health systems from extra care and legal liabilities.
All ETNA participants will receive an MRI scan and the study aims to establish the feasibility and methods for a larger study of diagnostic utility of MR brain imaging and estimate the effects of MRI on clinician decision making.
This study has been recruiting in the Emergency Dept, inpatient wards and TIA clinics since August 2018. We aim to recruit 270 participants and have almost reached our target!

Read more

ETNA

DASH Trial

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

ATTEST2 Trial

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2 Trial

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)